Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy.
Tartour E, Pere H, Maillere B, Terme M, Merillon N, Taieb J, Sandoval F, Quintin-Colonna F, Lacerda K, Karadimou A, Badoual C, Tedgui A, Fridman WH, Oudard S. Tartour E, et al. Among authors: terme m. Cancer Metastasis Rev. 2011 Mar;30(1):83-95. doi: 10.1007/s10555-011-9281-4. Cancer Metastasis Rev. 2011. PMID: 21249423 Review.
Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands.
Conforti R, Ma Y, Morel Y, Paturel C, Terme M, Viaud S, Ryffel B, Ferrantini M, Uppaluri R, Schreiber R, Combadière C, Chaput N, André F, Kroemer G, Zitvogel L. Conforti R, et al. Among authors: terme m. Cancer Res. 2010 Jan 15;70(2):490-500. doi: 10.1158/0008-5472.CAN-09-1890. Epub 2010 Jan 12. Cancer Res. 2010. PMID: 20068181
IL-18 induces PD-1-dependent immunosuppression in cancer.
Terme M, Ullrich E, Aymeric L, Meinhardt K, Desbois M, Delahaye N, Viaud S, Ryffel B, Yagita H, Kaplanski G, Prévost-Blondel A, Kato M, Schultze JL, Tartour E, Kroemer G, Chaput N, Zitvogel L. Terme M, et al. Cancer Res. 2011 Aug 15;71(16):5393-9. doi: 10.1158/0008-5472.CAN-11-0993. Epub 2011 Jul 1. Cancer Res. 2011. PMID: 21724589
Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells.
Terme M, Ullrich E, Aymeric L, Meinhardt K, Coudert JD, Desbois M, Ghiringhelli F, Viaud S, Ryffel B, Yagita H, Chen L, Mécheri S, Kaplanski G, Prévost-Blondel A, Kato M, Schultze JL, Tartour E, Kroemer G, Degli-Esposti M, Chaput N, Zitvogel L. Terme M, et al. Cancer Res. 2012 Jun 1;72(11):2757-67. doi: 10.1158/0008-5472.CAN-11-3379. Epub 2012 Mar 16. Cancer Res. 2012. PMID: 22427351
Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.
Pere H, Tanchot C, Bayry J, Terme M, Taieb J, Badoual C, Adotevi O, Merillon N, Marcheteau E, Quillien VR, Banissi C, Carpentier A, Sandoval F, Nizard M, Quintin-Colonna F, Kroemer G, Fridman WH, Zitvogel L, Oudard SP, Tartour E. Pere H, et al. Among authors: terme m. Oncoimmunology. 2012 May 1;1(3):326-333. doi: 10.4161/onci.18852. Oncoimmunology. 2012. PMID: 22737608 Free PMC article.
Modulation of immunity by antiangiogenic molecules in cancer.
Terme M, Colussi O, Marcheteau E, Tanchot C, Tartour E, Taieb J. Terme M, et al. Clin Dev Immunol. 2012;2012:492920. doi: 10.1155/2012/492920. Epub 2012 Dec 24. Clin Dev Immunol. 2012. PMID: 23320019 Free PMC article. Review.
52 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page